Glucotrack Inc. Files Definitive Additional Materials
Ticker: GCTK · Form: DEFA14A · Filed: Oct 31, 2025 · CIK: 1506983
Sentiment: neutral
Topics: proxy-statement, filing-update, regulatory
TL;DR
Glucotrack filed more docs, no fee. Check it out.
AI Summary
Glucotrack, Inc. filed a DEFA14A on October 31, 2025, indicating it is a definitive additional material filing. The company, formerly known as Integrity Applications, Inc., is based in Rutherford, NJ, and operates in the surgical and medical instruments sector. This filing does not appear to involve a fee, as indicated by the 'No fee required' checkbox.
Why It Matters
This filing provides updated or supplementary information to shareholders, which could contain important details regarding company operations, proposals, or other material events.
Risk Assessment
Risk Level: low — This filing is a routine administrative document (DEFA14A) and does not inherently present new financial or operational risks.
Key Players & Entities
- Glucotrack, Inc. (company) — Registrant
- Integrity Applications, Inc. (company) — Former company name
- Rutherford, NJ (location) — Company address
FAQ
What is the purpose of a DEFA14A filing?
A DEFA14A filing, or Definitive Additional Materials, is used to disseminate proxy materials to shareholders after the initial proxy statement has been filed.
When was Glucotrack, Inc. formerly known as Integrity Applications, Inc.?
Glucotrack, Inc. was formerly known as Integrity Applications, Inc. until March 28, 2022.
What is Glucotrack, Inc.'s Standard Industrial Classification (SIC) code?
Glucotrack, Inc.'s SIC code is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Was there a filing fee associated with this DEFA14A filing?
No, the filing indicates that no fee was required for this filing.
What is the filing date of this DEFA14A document?
This DEFA14A document was filed on October 31, 2025.
Filing Stats: 332 words · 1 min read · ~1 pages · Grade level 9.9 · Accepted 2025-10-31 16:05:27
Filing Documents
- formdefa14a.htm (DEFA14A) — 11KB
- formdefa14a_001.jpg (GRAPHIC) — 3KB
- 0001493152-25-020376.txt ( ) — 16KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to §240.14a-12 Glucotrack, Inc. (Name of Registrant as Specified in Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. Supplement to Proxy Statement for Adjourned Special Meeting of Stockholders to be held November 7, 2025 This supplement, dated October 31, 2025, supplements the definitive proxy statement (the “Proxy Statement”) of Glucotrack, Inc. filed with the Securities and Exchange Commission on October 3, 2025 relating to the Company’s Special Meeting of Stockholders (the “Special Meeting”) previously scheduled to be held on October 31, 2025, at https://www.virtualshareholdermeeting.com/GCTK2025M2 at 12:00 p.m. (Eastern Time). The Special Meeting was called to order at 12:00 p.m. (Eastern Time), on Friday, October 31, 2025 and then adjourned. Notice is hereby given that the Special Meeting has been adjourned and will reconvene at 12:00 p.m. (Eastern Time) on Friday, November 7, 2025. The Special Meeting will be held at https://www.virtualshareholdermeeting.com/GCTK2025M2. No changes have been made to the record date or the proposals to be brought before the Special Meeting, which are presented in the Proxy p.m. (Eastern Time) on November 6, 2025, are entitled to vote at the Special Meeting to be held on November 7, 2025, and may participate in the meeting using the control number included in the previously-distributed proxy materials.